To assess if IL-1α deficiency in tumor cells affects tumor progression in mice, we created IL-1α knock-out 4T1 cells (4T1 IL-1α KO) using the CRISPR/Cas9 approach. The gene discussed is IL1A; the disease is neoplasm.